CD19‐targeting chimeric antigen receptor T‐cell therapy is safe and effective for intra‐cardiac B cell non‐Hodgkin lymphoma
CAR-T therapy can be effective and safe in the treatment of B-cell blood cancers with intra-cardiac disease.
Authors
- Kathleen P. L. Cheok
- Arjun K. Ghosh (ORCID: https://orcid.org/0000-0003-4992-2412)
- Claire Roddie (ORCID: https://orcid.org/0000-0002-4901-5858)
- Maeve A O'Reilly (ORCID: https://orcid.org/0000-0002-2702-397X)
- Samuel D. Clark (ORCID: https://orcid.org/0000-0001-9494-4632)
- Charlotte Manisty (ORCID: https://orcid.org/0000-0003-0245-7090)
- Rajesh Puranik
- Daniel Chen (ORCID: https://orcid.org/0000-0002-5302-276X)
- John Malcolm Walker (ORCID: https://orcid.org/0000-0002-8559-7218)
- Ryan Low (ORCID: https://orcid.org/0000-0002-1500-3277)
Institutions
- University College Hospital (GB)
- The University of Sydney (AU)
- St Bartholomew's Hospital (GB)
- University College London Hospitals NHS Foundation Trust (GB)
- Barts Health NHS Trust (GB)
- Royal Prince Alfred Hospital (AU)
- London Cancer (GB)
- St George Hospital (AU)
- Sydney Local Health District (AU)
- University College London (GB)
Publication Details
- Journal
- eJHaem
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1002/jha2.1020
- Citations
- 2
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.57